Advertisement
The list of conditions that put people at risk for severe COVID-19 illness has been expanded by the U.S. Centers for Disease Control and Prevention.

CDC Updates List of Who Is at Highest Risk for COVID-19

0
Agency now says risk among adults increases steadily with age, and is not limited to those over 65
Triple therapy

Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD

0
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
It is possible to predict the likelihood of testing positive for COVID-19

Model May Help Predict Risk for Testing Positive for COVID-19

0
Risk reduced with pneumococcal polysaccharide, flu vaccine; melatonin, paroxetine, or carvedilol use
Sex and ethnicity differential patterns of COVID-19 positivity are not explained by cardiometabolic

Sex, Ethnic Differential Patterns of COVID-19 Unexplained

0
Increase in COVID-19 for men, BAME not due to cardiometabolic, sociodemographic, behavioral factors
As COVID-19 cases surge in Texas

Texas Pauses Reopening as COVID-19 Cases Rise

0
Currently, state has more than 4,300 hospitalized COVID-19 patients
Among women of reproductive age with COVID-19

Risk for Hospitalization Up for Pregnant Women With COVID-19

0
Pregnant women with COVID-19 more likely to be admitted to ICU, receive mechanical ventilation
Characteristics that are independently associated with hospitalization for COVID-19 include older age

Older Age, Black Race, Diabetes Up Hospitalization in COVID-19

0
Other characteristics independently associated with hospitalization include male sex, smoking, obesity
Patients with COVID-19 mount a marked and appropriate acute cortisol stress response

Patients With COVID-19 Mount Acute Cortisol Stress Response

0
High cortisol concentrations associated with increased mortality, reduced median survival
Use of tocilizumab to target cytokine release syndrome seems beneficial for patients with COVID-19

Tocilizumab Shows Promise for Treatment of COVID-19

0
Tocilizumab improves oxygenation and inflammatory biomarkers, may improve survival in severe disease
French drugmaker Sanofi has shortened its timeline to get a COVID-19 vaccine on the market.

Sanofi Speeds COVID-19 Vaccine Efforts

0
Company says it may be able to get a vaccine approved by regulators as early as the first half of 2021